Brain Tumor (After Recovery), Cerebral Palsy (CP), Encephalitis
Conditions
Brief summary
This study aims to explore the effects of an occupational therapy program combined with music therapy elements on children 5-12 years old with neurological disorders including those with neurogenic scoliosis. Occupational therapy programs typically focus on improving motor and cognitive functions to enhance the child's overall participation and daily functioning. Music has been shown to positively affect brain areas involved in emotions, memory, and language, and may reduce stress and increase feelings of happiness. The study will measure changes in biological markers such as blood pressure, oxygen saturation, heart rate, and respiratory rate, as well as improvements in functionality for upper limbs but also balance and walking ability after the therapy program. These markers can provide valuable information about the physical health and quality of life of the children, which is currently lacking for the Greek population. By investigating these biological indicators along with functional outcomes, this research hopes to offer new insights into the benefits of combining music therapy with occupational therapy. This may encourage better engagement from families and support rehabilitation specialists in demonstrating the value of their interventions even before functional improvements become noticeable
Interventions
this research hopes to offer new insights into the benefits of combining music therapy with occupational therapy.
standard treatment
Sponsors
Study design
Eligibility
Inclusion criteria
Diagnosis of a neurological condition with established neurological signs (e.g., motor or cognitive impairments) * Cerebral Palsy (GMFCS levels I-II), * Brain infections (e.g., encephalitis), * Brain neoplasms * Ability to follow simple instructions and participate in an occupational therapy program, * Medical clearance to participate in physical activity
Exclusion criteria
* Degenerative neurological diseases, * Metabolic disorders affecting the nervous system, * Neuromuscular disorders, including muscular dystrophy and congenital myopathies, * Peripheral nervous system damage, * Current use of corticosteroids, * Botulinum toxin injection within 30 days prior to the intervention program, * Hearing loss or diagnosed deafness
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 10M WALK TEST | From enrollment to the end of treatment at 6weeks | WALKING ABILITY |
| pediatric balance scale | From enrollment to the end of treatment at 6 weeks | balance Pediatric Balance Scale (PBS) is used, specifically the Greek validated version (Pediatric Balance Scale - Greek version, PBS-GR), as translated and cross-culturally adapted by Bania et al. (2023). The scale ranges from 0 to 56, with higher scores indicating better balance performance and a better outcome. The PBS-GR has been shown to have high interrater reliability in children with movement impairment |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| blood pressure | Arterial blood pressure will be measured using an automated electronic sphygmomanometer (mmHg). Measurements will be taken in a seated position after 5 minutes of rest, immediately before and immediately after (45 min) each therapy session. | PHYSIOLOGICAL BIOMARKERS |
| SaO2 oxygen saturation | Oxygen saturation will be measured non-invasively using a fingertip pulse oximeter (%). Measurements will be taken in a seated position, after 5 minutes of rest, immediately before and immediately after each (45 min) therapy session. | physiological marker |
| heart rate | Heart rate will be measured non-invasively using an electronic sphygmomanometer (beats per minute, bpm). Measurements will be taken in a seated position, after 5 minutes of rest, immediately before and immediately after (45 min)each therapy session | physiological marker |
| Respiratory Rate | Respiratory rate will be measured manually by counting visible thoracic movements (breaths per minute) for 60 seconds while the child is in a seated position before and after (45 min) each therapy session | physiological marker |
Countries
Greece